Recordings Feb 29, 2024 Webinar: Export controls and sanctions In the labyrinth of laws, regulations and sanctions, the international distribution of goods is a real challenge. What is the purpose of export c...
Expertise Dec 12, 2022 EEN: a support network for SMEs seeking partnerships throughout Europe and beyond With negotiations on the future of Swiss-EU relations at a standstill, Swiss SMEs need – now more than ever – to find partnerships to help grow t...
Third Party Event SEC Business Luncheon with Martin Hirzel – co-organized with Swissmem Zürich Switzerland
Event S-GE Gut zu wissen: Expansion Schweizer PropTechs nach Deutschland und Österreich May 10, 2023 11:00–14:00 Zürich 스위스
Fact-Finding Mission Switzerland goes NRW - Fact Finding Mission for Swiss Start-ups & Scale-ups to North Rhine-Westphalia/Germany Jun 20, 2023–Jun 21, 2023 독일
Fact Sheet Aug 30, 2022 EU Directives RoHS and WEEE: This is what Swiss firms need to know The EU directives RoHS II (2011/65/EU) and WEEE (2012/19/EU) of the European Commission restrict the usage of hazardous substances in electr...
Event S-GE Roundtable Liechtenstein: Beschaffung in Mittelosteuropa Sep 26, 2022 17:00–18:30 Schaan 리히텐슈타인
Event S-GE Wirtschaftslunch Entsendung nach Deutschland und Österreich Jun 27, 2022 11:30–14:00 Luzern 스위스
Webinar Cross-border e-commerce in Europe GOGLOBAL DAYS 2020 Sep 11, 2020 09:00–10:00 Online (CET/MEZ) 스위스
Actualités Mar 08, 2021 Debiopharm signe un contrat de plus de EUR 900 millions avec Merck Debiopharm a accordé une licence mondiale exclusive au géant pharmaceutique Merck pour le développement et la commercialisation de son médicament...
Webinar-Aufzeichnungen May 04, 2022 Entwicklung der Energieeffizienz in Europa Was ändert sich in Österreich und Deutschland? Wie beeinflusst es Ihre Internationalisierung? Erhalten Sie einen Überblick über die Änderungen in...
News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...